ANGO vs EMN · rev $292.5M vs P/E 21, rev $9.38B
AngioDynamics Inc (ANGO) versus Eastman Chemical Company (EMN) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
Eastman Chemical Company (EMN) is a specialty chemicals company listed on US.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported EMN revenue for 2024-12-31 was $9.38B. Net income was $908.0M. Revenue was up 1.9% from 2023-12-31 to 2024-12-31. EMN currently screens at market cap $8.21B and trailing P/E 20.8.
ANGO currently screens at market cap $378.5M. EMN currently screens at market cap $8.21B and trailing P/E 20.8.
Not investment advice. Open the ANGO and EMN stock pages for the full models.
Not investment advice.